Neuronetics STIM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $151.64M+69.5% | $149.16M+99.2% | $129.87M+78.6% | $111.11M+54.2% | $89.45M+22.2% | ||
| $78.91M+142% | $76.85M+271% | $64.38M+264% | $48.72M+153% | $32.64M+64.6% | ||
| $72.72M+28.0% | $72.31M+33.5% | $65.5M+19.0% | $62.39M+18.2% | $56.81M+6.4% | ||
| 48%-15.6pp | 48.5%-23.8pp | 50.4%-25.3pp | 56.2%-17.1pp | 63.5%-9.4pp | ||
| $6.33M-47.4% | $6.58M-48.4% | $10.69M+16.1% | $11.6M+29.7% | $12.04M+32.7% | ||
| $46.2M+0.4% | $47.46M+4.0% | $45.53M-4.2% | $45.56M-4.7% | $45.99M-2.3% | ||
| $49.61M+32.3% | $49.7M+63.9% | $47.15M+82.6% | $43.51M+76.0% | $37.5M+51.4% | ||
| $102.14M+6.9% | $103.74M+16.9% | $103.36M+25.2% | $100.66M+23.6% | $95.53M+18.1% | ||
| $102.14M+6.9% | $103.74M+16.9% | $103.36M+25.2% | $100.66M+23.6% | $95.53M+18.1% | ||
| -$29.42M+24.0% | -$31.44M+9.1% | -$37.87M-37.6% | -$38.27M-33.5% | -$38.72M-40.8% | ||
| -19.4%+23.9pp | -21.1%+25.1pp | -29.2%+8.7pp | -34.4%+5.3pp | -43.3%-5.7pp | ||
| $8.76M+18.7% | $8.42M+15.5% | $7.85M+6.5% | $7.37M+7.9% | $7.38M+23.1% | ||
| $1.49M-25.1% | $716K-71.9% | $1.11M-61.7% | $1.52M-49.7% | $1.99M-66.7% | ||
| —— | —— | —— | —— | —— | ||
| -$37.11M+23.5% | -$39M+10.8% | -$44.5M-22.2% | -$48.8M-50.3% | -$48.51M-76.1% | ||
| -24.5%+29.8pp | -26.1%+32.2pp | -34.3%+15.8pp | -43.9%+1.1pp | -54.2%-16.6pp | ||
| -$0.54+59.1% | -$0.59+57.2% | -$0.83+32.0% | -$1.14-2.7% | -$1.32-38.9% | ||
| -$0.54+59.1% | -$0.59+57.2% | -$0.83+32.0% | -$1.14-2.7% | -$1.32-38.9% | ||
| 269M+75.2% | 260.9M+115% | 226.7M+91.4% | 189.6M+62.0% | 153.5M+32.8% | ||
| 269M+75.2% | 260.9M+115% | 226.7M+91.4% | 189.6M+62.0% | 153.5M+32.8% | ||
| $1.49M-25.1% | $716K-71.9% | $1.11M-61.7% | $1.52M-49.7% | $1.99M-66.7% | ||
| $151.64M+69.5% | $149.16M+99.2% | $129.87M+78.6% | $111.11M+54.2% | $89.45M+22.2% | ||
| -$29.42M+24.0% | -$31.44M+9.1% | -$37.87M-37.6% | -$38.27M-33.5% | -$38.72M-40.8% | ||
| -$26.12M+28.0% | -$27.97M+13.9% | -$34.72M-36.7% | -$35.5M-33.7% | -$36.3M-42.6% | ||
| -$26.12M+28.0% | -$27.97M+13.9% | -$34.72M-36.7% | -$35.5M-33.7% | -$36.3M-42.6% | ||
| -17.2%+23.4pp | -18.8%+24.6pp | -26.7%+8.2pp | -32%+4.9pp | -40.6%-5.8pp | ||
| -$29.42M+24.0% | -$31.44M+9.1% | -$37.87M-37.6% | -$38.27M-33.5% | -$38.72M-40.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Neuronetics's revenue?
- Neuronetics (STIM) generated $151.6M in revenue over the trailing twelve months, up 69.5% year over year.
- Is Neuronetics profitable?
- Neuronetics is not currently profitable: it reported a net loss of $37.1M over the trailing twelve months, a -24.5% net margin.
- What are Neuronetics's profit margins?
- Gross margin is 48.0% and operating margin is -19.4%, with a -24.5% net margin.
- What is Neuronetics's earnings per share?
- Neuronetics's diluted EPS over the trailing twelve months is $-0.54.
- Where does Neuronetics's income statement data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
